2021/05: Implications of the ICH E9 estimand addendum on how we develop, run, and analyse clinical trials

Invited talk within workshop on innovative and complex trials organized jointly by interfarma and ANVISA (the Brazilian Health Authority, virtual event).

The recording of the session is available here on interfarma’s youtube channel.

Related